multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (female, 79 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy; Homo sapiens (male, 78 years) substantia nigra tissue associated with Parkinson's disease, cerebral amyloid angiopathy, mild cognitive impairment; ... and 14 more samples

multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples

multiplexed sample: Homo sapiens (male, 74 years) putamen tissue; Homo sapiens (male, 72 years) substantia nigra tissue associated with Parkinson's disease; ... and 10 more samples